Submitted by Anonymous (not verified) on 9 August 2024 - 9:31
Human medicines European public assessment report (EPAR): Apidra, insulin glulisine, Date of authorisation: 27/09/2004, Revision: 33, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Apidra, insulin glulisine, Date of authorisation: 27/09/2004, Revision: 33, Status: Authorised